Comparison of Walking Parameters Between Idiopathic Toe Walking and Independent Walking Diparetic Cerebral Palsy
Comparison of Walking Parameters Between Idiopathic Toe Walking Children and Children With Independent Walking Diparetic Cerebral Palsy
Study Overview
Status
Intervention / Treatment
Detailed Description
It is an observational study. The aim of the observational study is to compare static, kinematic and kinetic parameters with normal gait parameters in cases with Idiopathic toe walking (ITW) and Diparetic Cerebral Palsy (DCP) who have Gross Motor Function Classification System 1 level with the 3D Gait Analysis method, and to enable the early diagnosis of DCP and ITW. Male and female cases aged between 3-18 years will be included. This study will be carried out at Acıbadem Altunizade Hospital. 51 cases will be included in our study. These cases will be divided into three groups. The first group will consist of patients diagnosed with idioaptic toe walking (n:17), the second group will be composed of diparetic cerebral palsy (n:15) with independent ambulation, and the third group will be the control group (n:19). First, the demographic information of the cases will be recorded. With 3D walking analysis, kinetic, kinematic and static data will be collected. The analysis of the obtained data will be done with Polygon Software (Vicon, Oxford, UK). Evaluated kinetic, kinematic and static parameters will be compared between three groups.
Is the lower extremity compensation of children with diparetic cerebral palsy who can walk independently more than children with idiopathic toe walking?
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Istanbul, Turkey
- Acıbadem Altunizade Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Voluntary consent from family
- Diagnosed with idiopathic toe walking and spastic diparesis between the ages of 3-18.
- Cases with GMFCS 1
- The patients who applied to the healthy children's clinic, showed typical development, did not have any musculoskeletal and neurological problems, and wished to voluntarily participate in the study were included in the control group.
Exclusion Criteria:
- Refusing to participate in the study
- Under the age of 3 and over the age of 18
- Not at GMFCS 1 level
- Cases who did not have any orthopedic problems other than accompanying toe walking were excluded from the study.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
ITW Group
3D gait analysis was applied to children with idiopathic toe walking.
Static, kinematic and kinetic walking parameters were evaluated.
|
3D gait analysis was applied to children.
Static, kinematic and kinetic walking parameters were evaluated
|
|
DCP Group
3D gait analysis was applied to diparetic children who were able to walk independently.
Static, kinematic and kinetic walking parameters were evaluated.
|
3D gait analysis was applied to children.
Static, kinematic and kinetic walking parameters were evaluated
|
|
Healthy Group
3D gait analysis was applied to healthy children.
Static, kinematic and kinetic walking parameters were evaluated.
|
3D gait analysis was applied to children.
Static, kinematic and kinetic walking parameters were evaluated
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
3D Gait Analysis
Time Frame: Baseline
|
Sixteen markers defined according to the Modified Helen Heyes protocol are applied to certain anatomical regions of both lower extremities.
3D gait analysis can precisely calculate joint angles and movement patterns in all three planes.
Collect spatio-temporal data.
|
Baseline
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Fatih Erol, Biruni University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- FEROL
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.